Polymyositis: Difference between revisions
No edit summary |
No edit summary |
||
Line 55: | Line 55: | ||
<br> | <br> | ||
== Medications == | == Medications<sup>1</sup> == | ||
Earlier treatment is always better – your doctor will decide based on your symptoms what treatment will be more tailored to you. There have not been very many scientific studies which effects insurance coverage and you should be closely monitored for adverse side effects: | |||
*Corticosteroids | |||
*Immunosupressive therapies (If cortico-steroids aren’t working)<br>1. Corticosteroid sparing agents (Azasan, Imuran, Trexall, Methotrexate, Rheumatrex). <br>2. Intravenous immunoglobulin (IVIG). <br>3. Tacrolimus (Prograf) <br>4. Cyclophosphamide (Cytoxan) <br>5. Cyclosporine (Gengraf, Neoral, Sandimmune) | |||
*Biological therapies (Severe Cases, only if the above two didn’t work)<br>1. Rituximab (Rituxan) <br>2. Tumor necrosis factor (TNF) inhibitors (Enbrel, Remicade) | |||
<br> | |||
== Diagnostic Tests/Lab Tests/Lab Values == | == Diagnostic Tests/Lab Tests/Lab Values == |
Revision as of 22:59, 17 April 2013
Original Editors - Chris Pyles & Kayla Thiesen from Bellarmine University's Pathophysiology of Complex Patient Problems project.
Lead Editors - Your name will be added here if you are a lead editor on this page. Read more.
Definition/Description1,2[edit | edit source]
Polymyositis (PM) is a chronic inflammatory myopathy, which is classified as a persistence inflammatory muscle disease. PM affects striated muscle fibers, but spares smooth muscle throughout the body and can come on gradually over weeks or months. PM targets proximal musculature, with little to no pain, impairing strength and is characterized by an elevation of serum muscle enzymes and a wide variety of skin abnormalities, sometimes including cardiopulmonary impairments. Although no pain is present, some tenderness may occur directly over involved musculature, but all deep tendon reflexes are preserved. The general approach to treating polymyositis is through pharmacological and conservative treatment to increase strength and prevent development of extra-muscular disease in order to better outcomes for the patient.
Prevalence2[edit | edit source]
Current literature is unclear about the age of presentation – some articles state it mostly affects adults in their 30’s to 50’s, while other sources say the onset is in adults aged 50-70. Although research shows that it is rare to have an onset earlier than 18 years of age, it has been proven that females are more susceptible to PM than males with a ratio of 2:1. One in 100,000 people have PM with blacks more commonly diagnosed than whites.
Characteristics/Clinical Presentation1,2[edit | edit source]
Symptoms are symmetrical and can gradually appear or may fluctuate within short or long periods of time. Functionally, patients may have issues with grabbing a glass off of a high shelf, climbing stairs, or getting up or sitting down on a couch.
With progression of the disease, neck and shoulder girdle musculature can be involved resulting in minimal muscle contraction or paralysis.
Here is a summary of the signs and symptoms
- Proximal muscle weakness
- Difficult swallowing (dysphagia)
- Difficulty speaking
- Mild joint or muscle tenderness
- Fatigue
- Arthralagia
- Shortness of breathe
- Malnutrition
- Weight loss
- Calcium deposits
- Morning stiffness
As PM progresses, it can affect the upper esophagus as well as striated muscle fibers in the chest wall. As a result, patients can have more complex signs and symptoms such as:
- Aspiration pneumonia
- Respiratory failure
- Variety of cardiovascular complications (i.e. CHF, arrhythmias)
- Interstitial lung disease
Associated Co-morbidities1,2,3,4[edit | edit source]
Since Polymyositis is a autoimmune disease, it is often associated with other autoimmune dieases and infectious disorders:
- Connective tissue diseases: lupus, RA, scleroderma, Sjogrens
- Cardiovascular disease: myocarditis, CHF, heart arrhythmias
- Lung disease: interstitial lung disease
- HIV/AIDS
- Raynauds Phenomenon
Medications1[edit | edit source]
Earlier treatment is always better – your doctor will decide based on your symptoms what treatment will be more tailored to you. There have not been very many scientific studies which effects insurance coverage and you should be closely monitored for adverse side effects:
- Corticosteroids
- Immunosupressive therapies (If cortico-steroids aren’t working)
1. Corticosteroid sparing agents (Azasan, Imuran, Trexall, Methotrexate, Rheumatrex).
2. Intravenous immunoglobulin (IVIG).
3. Tacrolimus (Prograf)
4. Cyclophosphamide (Cytoxan)
5. Cyclosporine (Gengraf, Neoral, Sandimmune) - Biological therapies (Severe Cases, only if the above two didn’t work)
1. Rituximab (Rituxan)
2. Tumor necrosis factor (TNF) inhibitors (Enbrel, Remicade)
Diagnostic Tests/Lab Tests/Lab Values[edit | edit source]
add text here
Etiology/Causes[edit | edit source]
add text here
Systemic Involvement[edit | edit source]
add text here
Medical Management (current best evidence)[edit | edit source]
add text here
Physical Therapy Management (current best evidence)[edit | edit source]
add text here
Alternative/Holistic Management (current best evidence)[edit | edit source]
add text here
Differential Diagnosis[edit | edit source]
add text here
Case Reports/ Case Studies[edit | edit source]
add links to case studies here (case studies should be added on new pages using the case study template)
Resources
[edit | edit source]
add appropriate resources here
Recent Related Research (from Pubmed)[edit | edit source]
see tutorial on Adding PubMed Feed
Failed to load RSS feed from http://eutils.ncbi.nlm.nih.gov/entrez/eutils/erss.cgi?rss_guid=1NGmwZeh8JwVIzrKgHG1LrDm0izTr7ViJiDkSYAY2BW5hiXsx0|charset=UTF-8|short|max=10: Error parsing XML for RSS
References[edit | edit source]
see adding references tutorial.